乌鲁木齐市维吾尔族长寿家族成员第二掌骨骨皮质的X线形态学测量分析

用Ｘ线形态学测量方法，对乌鲁木齐部分维吾尔族长寿老人及其家族成员的第二掌骨骨皮质进行了测量。结果表明１０￣３９岁组骨皮质厚度，皮质厚度指数，皮质面积随年龄增长而增大，３０￣３９岁组达到峰值，其中骨皮质厚度、皮质面积的数值男性〉女性，３０￣３９岁组差别有显著性。４０岁以后各组数值开始下降，其下降速度女性快于男性，９０岁以上组最为明显，有显著性差异。     

经动脉化疗栓塞兔VX2肝癌后早期肿瘤细胞凋亡

目的　研究介入治疗兔VX2肝癌肿瘤细胞凋亡的早期动态改变 .方法　建立 2 7只新西兰大白兔VX2肝癌模型 ,随机分成肝动脉化疗栓塞组 (Transarterialchemoembolization ,TACE)、灌注化疗组 (Transarterialinfusion ,TAI)、灌注肝素生理盐水组 (对照组 ,Control) ,每组各 9只 .介入治疗后每组再随机分成 3个亚组 ,每亚组 3只 .在治疗后第2 4、72、12 0小时分别处死 3组中一亚组 ,取材肿瘤生长活跃的外带组织用流式细胞仪AnnexinV和PI双标记法定量检测细胞凋亡 ,组织病理切片苏木精 -伊红染色 (HE染色 )和甲基绿 -派洛宁染色 (MG -P染色 )光镜下形态学方法观察不同时间肿瘤细胞的凋亡变化 .结果　TACE、TAI、Control组在治疗后 2 4、72、12 0小时流式细胞仪法定量检测肿瘤细胞凋亡比率分别为 11.4 4± 2 .15、10 .99± 1.74、6 .0 0± 0 .5 8,5 .84± 0 .6 8、4 .6 5± 0 .11、2 .88± 1.2 3和 2 .80± 0 .15、2 .19± 1.6 9、2 .5 1± 2 .13.TACE、TAI、Control组凋亡在各时间点均有显著差异 (p <0 .0 1) ,TACE组 2 4、72小时的凋亡明显高于 12 0小时 (p <0 .0 5 ) .TACE组诱导的肿瘤细胞凋亡比率明显高于TAI、Control组 ;TACE组诱导的肿瘤细胞早期凋亡比率随时间呈下降趋势 ,在 12 0小时凋亡仍明显高于其     

正丁醇提取的低分子量宫颈癌细胞表面抗原

本实验采用正丁醇提取方法以研究甲基胆蒽诱发的小鼠宫颈癌(U_(14))细胞表面抗原。用2.5%正丁醇溶液对U_(14)细胞进行提取所获得的正丁醇粗提物(CBE),经Lowry法测得其蛋白含量为147微克/毫升;在SDS-PAGE中显出8条区带,分子量为18-70kD;用ELISA检测表明CBE与抗宫颈癌单克隆抗体(AU_(14-1))和多克隆抗体均呈阳性反应。结果证明CBE系低分子量的宫颈癌细胞表面抗原,其中含有能够与AU_(14-1)发生免疫反应的肿瘤抗原决定簇。     

Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort

Purpose

There is presently an ongoing debate on the relative merits of suggested criteria for spirometric airway obstruction. This study tests the null hypothesis that no superiority exists with the use of fixed ratio (FR) of forced expiratory volume in the first second (FEV1)/forced vital capacity (FVC) < 0.7 versus less than lower limit predicted (LLN) criteria with or without FEV1 <80% predicted in regards to future mortality.

肺淋巴管平滑肌瘤病临床病理学观察

目的 探讨肺淋巴管平滑肌瘤病临床、病理特征。方法 对5例肺淋巴管平滑肌瘤病临床资料进行收集分析,HE切片观察,采用免疫组织化学(SP法)检测平滑肌肌动蛋白(SMA)、HMB45、基质金属蛋白酶(MMP)2、孕激素受体(PR)、雌激素受体(ER),并进行文献复习。结果 肺淋巴管平滑肌瘤病是原因不明的肺部疾病,只发生在女性,特别是绝经前妇女。临床表现为呼吸困难,咯血,气胸和乳糜胸等。病理学检查显示不同成熟度平滑肌细胞在细支气管壁、肺泡壁、淋巴管壁和血管壁周围增生,肺实质呈囊性变。增生的平滑肌细胞免疫组织化学5例SMA、HMB45、MMP2均阳性;1例的ER和PR均阳性,1例仅ER阳性,1例仅PR阳性,1例的ER和PR均阴性。结论 育龄期妇女如反复出现自发性气胸、咯血、活动后呼吸困难应考虑肺淋巴管平滑肌瘤病的可能,病理检查可确定肺淋巴管平滑肌瘤病的诊断。     

Intravenous tufted angioma

A case of a rare vascular tumor, intravenous tufted angioma, is described. A 51-year-old Japanese man presented with a 12x8 mm solitary reddish nodule on the right foot, which had been found at birth. Histologically, the tumor was confined to a malformed vein and was characterized by nodular aggregates of plump cells. The aggregates showed a compact proliferation of round cells, including capillary-forming cells. Venous angiomatous areas were also observed. No multinucleated giant cells were seen. Immunohistochemically, the capillary-forming cells in the aggregates and the endothelial cells in the angiomatous areas were positive for endothelial markers (factor VIII-related antigen, CD31, CD34). Pericyte-like cells expressing alpha-smooth muscle actin and muscle actin, and macrophage-like cells, which stained for factor XIIIa, were intermingled in the cellular aggregates. Flow cytometric analysis showed diploidy. The tumor may be a hamartomatous lesion modified by secondary reactive changes, and it may represent a distinctive clinicopathological entity that is closely related histogenetically and perhaps pathologically to tufted angioma and the recently described "giant cell angioblastoma".     

非小细胞肺癌中p16 INK4／CDKN2基因的缺失和点突变

目的为了探讨周期素依赖性激酶４抑制因子基因（ｐ１６ＩＮＫ４）与肺癌发生的关系。方法采用双重ＰＣＲ－ＳＳＣＰ和序列分析方法，对３１例原发性非小细胞肺癌中ｐ１６ＩＮＫ４基因的存在状况进行了研究。结果３例存在ｐ１６基因缺失（３／３１），其中１例整个ｐ１６基因发生缺失，另两例则分别为外显子１和外显子２缺失；ｐ１６基因点突变２例（２／３１），外显子１和外显子２各一例；并发现在这五例基因异常样品中，４例（２例缺失和２例点突变）样品均为淋巴转移的非小细胞肺癌（４／２０）。结论提示ｐ１６基因失活和某些非小细胞肺癌（５／３１）的发生有关，并且可能发生在癌症的晚期。     

Fine-needle aspiration biopsy of multiple myeloma in a patient with renal-cell carcinoma: A case report

A case of multiple myeloma diagnosed by fine-needle aspiration (FNA) biopsy and confirmed by laboratory studies in a patient with a history of renal-cell carcinoma is presented. The patient was diagnosed with renal-cell carcinoma of the right kidney and a radical nephrectomy was performed. Eighteen months after this diagnosis was made, the patient developed chest wall pain and was found to have osteolytic bone lesions of the ribs and vertebral bodies. FNA of an osteolytic rib lesion disclosed multiple myeloma. Additional laboratory studies confirmed the diagnosis of multiple myeloma. This case report demonstrates the value of FNA as a diagnostic tool for the follow-up of cancer patients, the subsequent discrimination between metatastic lesions and a second primary malignancy, and the cytology of multiple myeloma.     

CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype

CD4+CD56+ hematodermic neoplasms (HNs) with initial presentation in the skin are characterized by highly aggressive behavior and poor prognosis. Recent studies indicate that malignant cells, which are devoid of common T-, B-, NK-, and myeloid lineage markers, may be of plasmacytoid dendritic cell (pDC) origin. We undertook a study to assess the expression of several pDC-associated molecules on a series of 5 CD4+CD56+ HN cases. CD123 was expressed in all 5 cases, with some heterogeneity in individual cases. All but one case revealed fine membranous BDCA-2 staining of the dermal infiltrate. pDC-like phenotype of the malignant infiltrating cells was confirmed by costaining of BDCA-2+ cells with CD123 and CD4. MxA protein, representing the surrogate marker for lesional type I interferon activity, was expressed in 4 of 5 evaluated cases. Our findings further substantiate the putative pDC origin of CD4+CD56+ HNs.     

组蛋白去乙酰化酶抑制剂与5-FU合用对肝癌细胞HepG2的影响

目的：探讨MS-275和5-Fu联用对HepG2细胞周期和凋亡的影响，并对其机制进行初步探讨。方法：将细胞分成对照组、MS-275组、5-FU组和联合用药组。流式细胞仪检测各组细胞凋亡和周期变化；Westernblot分析各组Bcl-2、Bax、CyclinD1、P21蛋白表达。结果：MS-275和5-Fu联用能抑制肝癌细胞生长，诱导G0—G1期阻滞，促进细胞凋亡。上述效应具有时间和剂量依赖性。二者联用可以使P21蛋白上调，Bcl-2、CyclinD1蛋白下调，Bax蛋白无明显变化。结论：5-Fu和MS-275联用能提高HepG2细胞凋亡率和周期阻滞，其机制与下调CyclinD1、Bcl-2蛋白的表达、上调P21蛋白表达有关。